Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Proteomics Firm Geneka to Open Base in France

NEW YORK, Nov. 13 — Geneka Biotechnology will be opening an office in Strasbourg, France, toward the start of the new year, the company announced on Tuesday. 

The new office, which represents the company’s first international expansion, will be small at first and will have no associated lab space, said Jean Rousseau, director of international marketing and sales at Montreal-based Geneka. 

The company chose Strasbourg for its central location and proximity to Germany, Switzerland, and the Alsace region in western France, where a lot of important research into transcription factors is carried out, added Rousseau. 

“The concentration of the market is there for us,” he said. 

Geneka, which focuses on proteomic regulators, including transcription factors, co-activators, co-repressors, and chromatin associated proteins, will be recruiting locally to fill the new office.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more